IMI announces fiscal 2004 update conference call & webcast TORONTO, March 7 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc. (TSX: IMI, Amex: IME) today announced it will hold a conference call and webcast on Wednesday, March 9, 2005 at 10 a.m. (ET) to preview the company's fiscal 2004 year-end results and to provide an update on recent activities. The event will be hosted by Dr. Brent Norton, President and CEO; Ron Hosking, Vice President and CFO; and Sarah Borg-Olivier, Director, Communications. Please dial in five minutes prior to start time: Date: Wednesday, March 9, 2005 Time: 10 a.m. ET Webcast: http://www.imimedical.com/ or http://www.newswire.ca/ Conference Call Numbers: (416) 640-4127 (Toronto) (800) 814-4862 (North America) A webcast will be accessible for three months at http://www.imimedical.com/. A replay of the call will be available until Wednesday, March 16, 2005 by dialing (416) 640-1917 (Toronto) or (877) 289-8525 (North America) and entering access code 21116488 followed by the number sign. About IMI IMI is a world leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. IMI's cardiovascular products, which are branded as PREVU(x) Skin Sterol Test, are marketed and distributed worldwide by McNeil Consumer Healthcare, Canada. The company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast cancer test. IMI's head office is located in Toronto, and its research and product development facility is at McMaster University in Hamilton, Ontario. For further information, please visit http://www.imimedical.com/. DATASOURCE: IMI International Medical Innovations Inc. CONTACT: Company Contact: Sarah Borg-Olivier, Director, Communications, T: (416) 222-3449, ; U.S. Investor Contact: Andrea Faville, The Investor Relations Group, T: (212) 825-3210,

Copyright